1. MicroRNA-23a-3p Down-Regulation in Active Pulmonary Tuberculosis Patients with High Bacterial Burden Inhibits Mononuclear Cell Function and Phagocytosis through TLR4/TNF-α/TGF-β1/IL-10 Signaling via Targeting IRF1/SP1
   Yung-Che Chen et al, 2020, International Journal of Molecular Sciences CrossRef
2. Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer
   Jingsheng Yuan et al, 2019, Cancer Letters CrossRef
3. MiR-23a-3p promoted G1/S cell cycle transition by targeting protocadherin17 in hepatocellular carcinoma
   Yien Xiang et al, 2020, Journal of Physiology and Biochemistry CrossRef
4. Next generation sequencing uncovers multiple miRNAs associated molecular targets in gallbladder cancer patients
   Rahul Saxena et al, 2023, Scientific Reports CrossRef
5. miR‐383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1
   Peiqi Wan et al, 2018, Journal of Cellular Biochemistry CrossRef
6. Integration of transcriptomes analysis with spectral signature of total RNA for generation of affordable remote sensing of Hepatocellular carcinoma in serum clinical specimens
   Ibrahim H. Aboughaleb et al, 2021, Heliyon CrossRef
7. MicroRNAs and clinical implications in hepatocellular carcinoma
   Amal Ahmed Mohamed et al, 2017, World Journal of Hepatology CrossRef
8. MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1
   Kun Dong et al, 2020, Biochemical and Biophysical Research Communications CrossRef
9. Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients
   Sara M. Abdo et al, 2023, Journal of Genetic Engineering and Biotechnology CrossRef
10. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs
    Srinivas V. Koduru et al, 2018, Scientific Reports CrossRef
11. Noncoding RNAs: the shot callers in tumor immune escape
    Lei Liu et al, 2020, Signal Transduction and Targeted Therapy CrossRef
12. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
    Karthik Dhatchinamoorthy et al, 2021, Frontiers in Immunology CrossRef
13. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison
    Sijia Shen et al, 2016, Scientific Reports CrossRef
14. GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability
    Wang Lai Hu et al, 2018, Nature Cell Biology CrossRef
15. Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook
    Tao Chen et al, 2024, Journal of Zhejiang University-SCIENCE B CrossRef
16. The clinical significance and biological function of interferon regulatory factor 1 in cholangiocarcinoma
    Peiqi Wan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
17. The Role of Interferon Regulatory Factors in Liver Diseases
    Chuanfei Zeng et al, 2024, International Journal of Molecular Sciences CrossRef
18. microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
    Ning Wang et al, 2018, Cancers CrossRef
19. The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Chunye Zhang et al, 2022, Gastroenterology Insights CrossRef
20. Berberine modulates ASK1 signaling mediated through TLR4/TRAF2 via upregulation of miR-23a
    Sali Sujitha et al, 2018, Toxicology and Applied Pharmacology CrossRef
21. RETRACTED: MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC
    Jing Quan et al, 2019, Biomedicine & Pharmacotherapy CrossRef
22. Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma
    Xiaoming Li et al, 2023, Human & Experimental Toxicology CrossRef
23. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway
    Jingjing Du et al, 2019, Toxicology and Applied Pharmacology CrossRef